Settlement risk

Climate unsettled

David Clark , chairman of the Wholesale Market Brokers Association, demystifies the OTC versus exchange settlement debate

What a difference a year makes

The foreign exchange business was a clear outlier in what has been a historic year for global financial markets. But no single entity experienced as significant a reversal of fortunes as a result of the market turbulence this year as settlement system…

Strong Q3 for FX derivatives

BASEL - Trading volumes in exchange-traded foreign exchange derivatives grew in the third quarter this year, despite an overall decline in volumes in exchange-traded derivatives, according to the Bank for International Settlements (BIS).

DealHub client consolidates trades

LONDON - Options Computer Limited (OCL) has deployed its DealHub internal trade netting tool with an existing client, enabling the bank to reduce more than 100,000 component trades to 1,000 aggregate trades, according to the vendor.

Bloomberg Tradebook back on track

NEW YORK - Bloomberg Tradebook is this week re-launching its foreign exchange electronic communications network after suffering up to eight weeks of outage as it sought to replace AIG as its central clearer.

Industry pushes to expand CLS coverage

LONDON - Panellists at the FX Week Europe Congress held in London last week applauded CLS for its role in alleviating settlement risk, but pushed for expansion to cover more counterparties, currencies and products.

UBS wins with front-to-back approach

UBS has retained its number one position as the best bank for foreign exchange prime brokerage in this year's FX Week Best Bank Awards. Deutsche and Citi followed in second and third places respectively.

OTC derivatives on the up

BASEL - The Bank for International Settlements' (BIS) semi-annual report has shown a significant increase in the growth of over-the-counter foreign exchange derivatives in the first half of this year.

You need to sign in to use this feature. If you don’t have a FX Markets account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an indvidual account here: